Practice of pharmacy; authorizing product fulfillment through central fill pharmacies under certain conditions; authorizing shared services. Effective date.
SB907 updates Oklahoma pharmacy law to expressly authorize two related operational models: central fill pharmacies and shared services between pharmacies. The bill defines “central fill,” “central fill pharmacy,” and “originating pharmacy,” and allows an originating pharmacy to send prescription fulfillment work to a central fill pharmacy when the pharmacies share ownership or have a written agreement, use a common electronic file or compatible technology, and comply with confidentiality and recordkeeping requirements. It also allows central fill pharmacies to return completed prescriptions to the originating pharmacy or, for non-controlled substances, send them directly to patients.
The bill sets detailed operational standards for central fill pharmacies and originating pharmacies. These include patient notification requirements, labeling rules identifying both the originating and filling pharmacy, shipping and storage standards to preserve drug integrity, tamper-evident packaging, policy-and-procedure manuals, record retention, and permit application and fee requirements. It also creates a separate section authorizing shared services such as data entry, prescription interpretation, drug utilization review, product verification, centralized fulfillment, and therapeutic intervention, subject to licensure, ownership or contract requirements, electronic access to records, and security protections.
SB907 would add new sections to Title 59 of the Oklahoma Statutes governing pharmacy practice, creating a legal framework for central fill and shared services operations. It would expand the permissible ways pharmacies can process prescriptions, while imposing compliance obligations on both originating and central fill pharmacies, including Board licensure, documentation, patient notice, labeling, shipping, and inspection requirements. The State Board of Pharmacy would also be directed to develop and implement a central fill permit and application process and could regulate these activities through rulemaking.
The available context shows no committee transcript or recorded votes, so there is no documented floor or committee debate to gauge sentiment directly. Based on the bill’s structure and sponsor action, the measure appears to be a technical and operational modernization bill intended to give pharmacies more flexibility in prescription fulfillment and shared back-office functions. The absence of recorded opposition or vote history suggests no clear public controversy is reflected in the provided materials.
The main points of potential contention are patient safety, privacy, and accountability versus operational efficiency. The bill addresses these concerns by requiring written agreements, shared electronic access, confidentiality protections, tamper-evident packaging, and detailed records, but critics could still question whether centralizing fulfillment increases the risk of errors or weakens direct pharmacist-patient interaction. Another possible issue is regulatory burden, since pharmacies must obtain permits, maintain manuals, and comply with Board oversight, while central fill pharmacies are exempted from wholesale distributor licensure when returning filled prescriptions to originating pharmacies.